CoronaryAtlas logo
CoronaryAtlas
Lysocardiolipin acyltransferase 1
Pathway / Lipid retention & oxidation

Lysocardiolipin acyltransferase 1

LCLAT1gene

LCLAT1 remodels cardiolipin affecting mitochondrial function and ischemic vulnerability.

Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleLipid remodeling; affects cardiolipin and mitochondrial lipid metabolism.
Also acts inMyocardial injury
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000172954

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable

Literature evidence(1)